Stem Cell Biology and Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 24713
Special Issue Editors
Interests: the use of synthetic retinoids and vitamins D as drug substances; cancer and normal stem cells; anticancer therapies; blood cell development; abnormalities in cancer stem cells
Special Issues, Collections and Topics in MDPI journals
2. Department of Pediatrics, Hospital Universitario de Salamanca, 37007 Salamanca, Spain
Interests: stem cells; pathogenesis and treatment of cancers; transgenic mouse models; leukemias; stem cell reprogramming
Interests: lymphoid tumors; functional genomics; computational biology; molecular genetics; childhood leukemogenesis
Special Issue Information
Dear Colleagues,
Many, if not all, cancers arise from the transformation of a stem/progenitor cell that gives rise to the cells of a tissue. At least two genetic insults are needed for cancer. The first gives rise to a cancer initiating cell (preleukemic) that remains dormant because these cells are found in persons who will never develop cancer. The second insult transforms the cancer initiating cell into a cancer stem cell that is required for cancer. These cells sustain a cancer, by generating a hierarchy of differentiating or partially differentiating cells, and they are also largely responsible for disease relapse and metastasis. There is the urgent need to develop new treatments for cancer that can eliminate cancer stem cells. There are two reasons. Conventional chemotherapeutics and radiotherapy are often highly effective against the bulk cells of a cancer, which are proliferating, but they spare cancer stem cells that are liable to lead to relapses. And, therapeutics that specifically target cancer stem cells may provide a bone fide cure for cancer. The aim of this Special Issue is to explore the nature of normal stem cells and cancer stem cells, the extracellular and intracellular controls on the behaviour of these cells, and how differences between normal stem cells and cancer stem cells might be exploited to provide new therapeutics.
Dr. Geoffrey Brown
Dr. Carolina Vicente-Dueñas
Dr. Isidro Sanchez-Garcia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- the nature of normal stem cells
- the nature of cancer stem cells
- cancer stem cell models
- cell lineage determination
- preleukemia
- genetic predisposition
- environmental triggers
- oncogenes
- intracellular controls
- extracellular controls
- cancer stem cell targeted therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.